Jacob Vincent Micallef - 26 Feb 2026 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Jacob Vincent Micallef
Issuer symbol
VNRX
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
27 Feb 2026, 16:30:44 UTC
Previous filing
23 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Micallef Jacob Vincent Chief Scientific Officer 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON /s/ Jacob Vincent Micallef 27 Feb 2026 0001651671

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +149,000 +35% $0.000000 577,489 26 Feb 2026 Direct F1
holding VNRX Common Stock 55,000 26 Feb 2026 By Spouse
holding VNRX Common Stock 38,113 26 Feb 2026 By Borlaug Limited F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 26, 2026, the reporting person was awarded 149,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
F2 The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.